Free tool
Healthcare stocks
We cover 270 companies in the Healthcare sector. The median market value in the group is $35.39B. Across the group, the median move over the past trading day is 0.00%. 71% of the 263 with a 200-day average trade above it. Price change over the past year runs from −20.8% to +79.7% across the middle 80 percent of the group, with a median of +15.9%. Across the group, 4 companies currently carry a tier A volume signal.
Other lists in this group
Table
270 of 2,199 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | 1,063.40 EUR | −0.47% | +17.71% | +68.40% |
| LLY | Eli Lilly and Company | $1,233.66 | +3.02% | +14.58% | +78.28% |
| LILY34.SA | Eli Lilly and Company | 211.20 BRL | +3.30% | +9.59% | +69.06% |
| JNJ.DE | Johnson & Johnson | 231.70 EUR | −2.53% | +32.60% | +54.31% |
| JNJ | Johnson & Johnson | $273.14 | +2.70% | +33.19% | +56.92% |
| JNJB34.SA | Johnson & Johnson | 93.72 BRL | +2.97% | +26.23% | +48.73% |
| 4AB.DE | AbbVie Inc. | 226.10 EUR | −2.54% | +17.94% | +29.69% |
| ABBV | AbbVie Inc. | $265.79 | +3.46% | +17.81% | +31.10% |
| ABBV34.SA | AbbVie Inc. | 85.03 BRL | +3.35% | +9.69% | +23.44% |
| MRCK34.SA | Merck & Co., Inc. | 100.37 BRL | +19.93% | +38.35% | +77.08% |
| 6MK.DE | Merck & Co., Inc. | 129.28 EUR | +11.62% | +44.70% | +83.96% |
| RHO.DE | Roche Holding AG | 400.20 EUR | −0.15% | +12.54% | +39.70% |
| MRK | Merck & Co., Inc. | $156.45 | +19.65% | +48.06% | +88.17% |
| NOT.DE | NOVARTIS AG N | 135.46 EUR | −3.15% | +18.61% | +27.82% |
| N1VS34.SA | Novartis AG | 82.08 BRL | +2.40% | +11.52% | +20.51% |
| NVS | Novartis AG | $159.98 | +2.48% | +18.99% | +31.84% |
| AZN.L | AstraZeneca PLC | 12,110.00 GBP | −6.41% | −10.89% | +1.98% |
| AZN.ST | AstraZeneca PLC | 1,568.00 SEK | −6.12% | −7.36% | +2.47% |
| AZN | AstraZeneca PLC | $169.66 | +0.01% | −6.39% | +7.60% |
| A1ZN34.SA | AstraZeneca PLC | 144.34 BRL | +0.85% | −12.75% | +1.51% |
| AMG.DE | Amgen Inc. | 378.10 EUR | +9.72% | +37.91% | +56.55% |
| AMGN34.SA | Amgen Inc. | 81.36 BRL | +17.28% | +69.77% | +47.86% |
| AMGN | Amgen Inc. | $442.24 | +17.54% | +36.94% | +56.64% |
| TMO | Thermo Fisher Scientific Inc. | $628.74 | +12.37% | +6.22% | +28.46% |
| TN8.DE | Thermo Fisher Scientific Inc. | 529.40 EUR | +4.71% | +5.35% | +27.50% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | 67.27 BRL | +13.34% | −0.04% | +22.09% |
| NVO | Novo Nordisk A/S | $48.66 | −2.03% | −3.71% | −10.46% |
| NOV.DE | Novo Nordisk A/S | 40.03 EUR | −10.35% | +20.19% | +11.69% |
| NOVO-B.CO | Novo Nordisk A/S | 299.25 DKK | −10.78% | −6.26% | −13.21% |
| N1VO34.SA | Novo Nordisk A/S | 30.64 BRL | −2.73% | −12.21% | −17.65% |
| NVO.WA | NVONORDSK | 171.66 PLN | −9.40% | −3.40% | −11.47% |
| ABT | Abbott Laboratories | $116.13 | +11.14% | −5.43% | −10.54% |
| ABTT34.SA | Abbott Laboratories | 49.85 BRL | +12.07% | −10.73% | −15.33% |
| ABL.DE | Abbott Laboratories | 99.80 EUR | +5.14% | −4.18% | −9.70% |
| GILD | Gilead Sciences, Inc. | $148.77 | +13.98% | +23.04% | +32.85% |
| GILD34.SA | Gilead Sciences, Inc. | 63.72 BRL | −81.00% | −81.40% | −78.95% |
| GIS.DE | Gilead Sciences, Inc. | 124.88 EUR | +6.55% | +21.56% | +29.53% |
| PFE.DE | Pfizer Inc. | 23.91 EUR | +7.95% | +15.85% | +18.09% |
| PFIZ34.SA | Pfizer Inc. | 36.50 BRL | +15.29% | +10.40% | +11.31% |
| PFE | Pfizer Inc. | $28.57 | +15.81% | +17.27% | +19.52% |
| DHR | Danaher Corporation | $215.97 | +9.91% | −6.06% | +4.52% |
| DHER34.SA | Danaher Corporation | 39.68 BRL | +11.43% | −10.83% | −0.75% |
| DAP.DE | Danaher Corporation | 184.70 EUR | +5.33% | −5.55% | +5.45% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | 469.95 EUR | +10.56% | +22.24% | +40.14% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | 88.83 BRL | +19.14% | −85.56% | −83.17% |
| VRTX | Vertex Pharmaceuticals Incorporated | $552.85 | +15.42% | +22.28% | +42.14% |
| BMY | Bristol-Myers Squibb Company | $67.92 | +8.57% | +28.36% | +49.31% |
| BMYB34.SA | Bristol-Myers Squibb Company | 349.41 BRL | +12.49% | +17.24% | +40.74% |
| BRM.DE | Bristol-Myers Squibb Company | 57.33 EUR | +2.36% | +27.03% | +46.24% |
| IUI1.DE | Intuitive Surgical, Inc. | 322.70 EUR | +0.77% | −32.18% | −20.90% |
| ISRG | Intuitive Surgical, Inc. | $371.84 | +4.21% | −33.83% | −20.62% |
| I1SR34.SA | Intuitive Surgical, Inc. | 95.70 BRL | +2.99% | −37.63% | −24.38% |
| SYK | Stryker Corporation | $330.59 | −1.83% | −4.80% | −14.79% |
| S1YK34.SA | Stryker Corporation | 84.97 BRL | +5.72% | −13.76% | −17.50% |
| SYK.DE | STRYKER CORP. R | 282.10 EUR | −7.33% | −4.56% | +34.76% |
| MDTC34.SA | Medtronic plc | 59.28 BRL | +12.98% | −77.33% | −76.08% |
| 2M6.DE | Medtronic plc | 79.84 EUR | +4.23% | −1.17% | +3.67% |
| MDT | Medtronic plc | $91.14 | +8.22% | −4.34% | +1.33% |
| SNY | Sanofi | $46.02 | +4.59% | +0.71% | −3.11% |
| SAN.PA | Sanofi | 78.28 EUR | −1.39% | +0.41% | −4.49% |
| SNW.DE | Sanofi | 78.32 EUR | −0.94% | +0.25% | −4.28% |
| MCK | McKesson Corporation | $905.09 | +6.47% | +10.01% | +33.71% |
| GS71.DE | GSK plc | 22.16 EUR | −6.46% | +6.95% | +31.93% |
| G1SK34.SA | GSK plc | 53.80 BRL | +4.47% | +1.87% | +28.14% |
| GSK | GSK plc | $52.07 | +0.17% | +6.73% | +34.79% |
| GSK.L | GSK plc | 1,890.50 GBP | −6.83% | +3.24% | +28.03% |
| M1CK34.SA | McKesson Corporation | 72.24 BRL | +4.56% | −93.69% | −92.48% |
| HCA | HCA Healthcare, Inc. | $428.76 | +10.05% | −8.71% | +6.96% |
| H1CA34.SA | HCA Healthcare, Inc. | 110.44 BRL | +11.12% | −13.17% | +3.95% |
| A58.DE | Elevance Health, Inc. | 344.10 EUR | +3.43% | +14.34% | −18.92% |
| E1LV34.SA | Elevance Health, Inc. | 410.80 BRL | +3.62% | +6.85% | +21.66% |
| ELV | Elevance Health, Inc. | $398.87 | +5.42% | +13.29% | +29.17% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | 706.90 EUR | +23.09% | +7.29% | −7.35% |
| ESL.DE | EssilorLuxottica Société anonyme | 162.35 EUR | −3.31% | −37.24% | −38.59% |
| REGN | Regeneron Pharmaceuticals, Inc. | $833.56 | +24.94% | +7.66% | +46.21% |
| EL.PA | EssilorLuxottica Société anonyme | 161.70 EUR | −4.12% | −37.66% | −37.89% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | 71.40 BRL | +25.51% | +2.94% | +37.96% |
| CI | The Cigna Group | $279.32 | −4.02% | +0.62% | −5.62% |
| C1IC34.SA | The Cigna Group | 59.58 BRL | −83.52% | −84.24% | −85.51% |
| CGN.DE | The Cigna Group | 238.50 EUR | −8.69% | +0.92% | −8.36% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | 7,050.00 JPY | +0.73% | −17.21% | +12.47% |
| B1SX34.SA | Boston Scientific Corporation | 64.19 BRL | +9.06% | −87.53% | −88.79% |
| BSX | Boston Scientific Corporation | $49.86 | +9.56% | −47.36% | −52.56% |
| BSX.DE | Boston Scientific Corporation | 42.22 EUR | +2.65% | −47.62% | −54.21% |
| MRK.DE | Merck KGaA | 138.40 EUR | −4.06% | +16.39% | +30.60% |
| ARGX | argenx SE | $1,019.49 | +14.70% | +21.37% | +50.52% |
| M1RN34.SA | Moderna, Inc. | 40.95 BRL | +195.88% | +382.90% | +494.34% |
| 0QF.DE | Moderna, Inc. | 118.40 EUR | +147.16% | +349.85% | +461.14% |
| MRNA | Moderna, Inc. | $158.83 | +185.51% | +414.68% | +526.55% |
| A1RG34.SA | argenx SE | 209.16 BRL | +18.17% | +11.37% | +44.49% |
| COR | Cencora, Inc. | $328.06 | +5.43% | −2.80% | +14.44% |
| CSL.AX | CSL Limited | 174.44 AUD | +45.95% | +2.75% | −17.14% |
| 4502.T | Takeda Pharmaceutical Company Limited | 5,885.00 JPY | +2.45% | +21.80% | +39.50% |
| TAK | Takeda Pharmaceutical Company Limited | $18.35 | +5.22% | +17.48% | +21.77% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | 92.25 BRL | +12.06% | +12.61% | +16.07% |
| BAYN.DE | Bayer Aktiengesellschaft | 48.48 EUR | +3.08% | +27.94% | +71.10% |
| CAH | Cardinal Health, Inc. | $237.92 | +3.74% | +15.93% | +64.25% |
| C1AH34.SA | Cardinal Health, Inc. | 1,222.80 BRL | +3.96% | +5.76% | +50.94% |
| BAY.WA | Bayer Aktiengesellschaft | 206.70 PLN | +0.68% | +31.69% | +71.25% |
| 207940.KS | Samsung Biologics Co.,Ltd. | 1,609,000.00 KRW | +3.87% | −4.40% | +2.60% |
| C1CO34.SA | Cencora, Inc. | 707.04 BRL | 0.00% | −22.88% | −12.17% |
| EW | Edwards Lifesciences Corporation | $90.87 | +9.43% | +6.49% | +12.38% |
| BOX.DE | Becton, Dickinson and Company | 168.80 EUR | +23.08% | +2.38% | +2.94% |
| EWL.DE | Edwards Lifesciences Corporation | 77.46 EUR | +5.33% | +7.79% | +10.23% |
| SHL.DE | Siemens Healthineers AG | 40.39 EUR | +12.44% | −6.30% | −12.35% |
| B1DX34.SA | Becton, Dickinson and Company | 195.72 BRL | +39.80% | −113.58% | −113.87% |
| BDX | Becton, Dickinson and Company | $189.78 | +19.42% | +24.62% | +26.17% |
| 7741.T | HOYA Corporation | 24,525.00 JPY | +3.55% | +2.32% | +29.26% |
| NTRA | Natera, Inc. | $336.71 | +30.49% | +47.14% | +107.24% |
| E1WL34.SA | Edwards Lifesciences Corporation | 105.71 BRL | 0.00% | −8.81% | −4.72% |
| MDLN | Medline Inc. | $35.64 | −10.23% | −12.26% | −13.07% |
| HUM | Humana Inc. | $389.71 | +2.25% | +48.10% | +32.71% |
| H1UM34.SA | Humana Inc. | 44.50 BRL | +0.29% | +39.03% | +24.30% |
| RVMD | Revolution Medicines, Inc. | $211.38 | +12.39% | +167.50% | +492.60% |
| HLN | Haleon plc | $10.18 | +2.41% | +3.15% | +6.56% |
| H6D0.DE | Haleon plc | 4.34 EUR | −3.10% | +2.77% | +4.86% |
| TEVA | Teva Pharmaceutical Industries Limited | $38.10 | +22.59% | +23.10% | +110.26% |
| HLN.L | Haleon plc | 369.80 GBP | −2.91% | −0.07% | +2.08% |
| I1DX34.SA | IDEXX Laboratories, Inc. | 578.89 BRL | +0.85% | −23.36% | −16.38% |
| IDXX | IDEXX Laboratories, Inc. | $550.01 | −1.11% | −17.91% | −14.24% |
| A | Agilent Technologies, Inc. | $154.77 | +12.24% | +12.65% | +30.69% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | 97.74 BRL | +24.04% | +17.29% | +94.70% |
| IX1.DE | IDEXX Laboratories, Inc. | 468.10 EUR | −2.09% | −17.59% | +17.97% |
| IQV | IQVIA Holdings Inc. | $259.42 | +21.67% | +15.11% | +37.97% |
| QTS.DE | IQVIA Holdings Inc. | 222.40 EUR | +19.51% | +15.38% | −3.91% |
| ONC | BeOne Medicines AG | $376.37 | +15.49% | +21.01% | +21.95% |
| V2EE34.SA | Veeva Systems Inc. | 43.28 BRL | +37.40% | +4.74% | −16.69% |
| WAT | Waters Corporation | $414.44 | +11.65% | +8.50% | +38.63% |
| 4578.T | Otsuka Holdings Co., Ltd. | 12,350.00 JPY | +8.48% | +36.48% | +58.81% |
| VEEV | Veeva Systems Inc. | $246.78 | +26.91% | +12.43% | −13.47% |
| VEE.DE | Veeva System Inc. R | 212.20 EUR | +19.28% | +13.08% | +13.96% |
| A1GI34.SA | Agilent Technologies, Inc. | 72.26 BRL | −78.40% | −81.18% | −77.11% |
| WATC34.SA | Waters Corporation | 476.58 BRL | 0.00% | −9.22% | +24.76% |
| ALC | Alcon Inc. | $73.37 | +9.05% | −4.99% | −8.71% |
| RPRX | Royalty Pharma plc | $62.07 | +5.69% | +61.27% | +75.10% |
| 2U3.DE | Alcon Inc. | 62.96 EUR | +3.86% | −4.24% | −10.05% |
| DC4.DE | DexCom, Inc. | 79.20 EUR | +19.28% | +40.28% | +21.55% |
| RMD | ResMed Inc. | $236.59 | +16.50% | −2.85% | −16.58% |
| I1LM34.SA | Illumina, Inc. | 232.57 BRL | +19.43% | +55.21% | +113.13% |
| RMD.AX | ResMed Inc. | 32.95 AUD | +13.82% | −8.56% | −24.73% |
| ILU.DE | Illumina, Inc. | 186.94 EUR | +10.93% | +64.33% | +119.28% |
| ILMN | Illumina, Inc. | $224.99 | +18.75% | +67.47% | +125.76% |
| D1EX34.SA | DexCom, Inc. | 9.23 BRL | +28.73% | +23.23% | +11.74% |
| DXCM | DexCom, Inc. | $89.16 | +21.52% | +33.99% | +17.38% |
| GEHC | GE HealthCare Technologies Inc. | $73.91 | +20.93% | −10.68% | −0.78% |
| 4568.T | Daiichi Sankyo Company, Limited | 2,923.00 JPY | +1.16% | −16.08% | −15.95% |
| IDP.DE | Biogen Inc. | 184.26 EUR | +3.59% | +22.59% | +57.35% |
| C1NC34.SA | Centene Corporation | 340.30 BRL | −2.49% | +53.30% | +116.81% |
| BIIB | Biogen Inc. | $220.77 | +10.31% | +24.15% | +61.90% |
| BIIB34.SA | Biogen Inc. | 188.29 BRL | +10.54% | +16.95% | +47.86% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $240.08 | −13.76% | −40.01% | −45.88% |
| CNC | Centene Corporation | $65.00 | +1.44% | +55.58% | +123.52% |
| ZTS | Zoetis Inc. | $77.29 | +0.48% | −38.09% | −49.59% |
| 068270.KS | Celltrion, Inc. | 193,000.00 KRW | +8.79% | −4.69% | +13.47% |
| Z1TS34.SA | Zoetis Inc. | 24.84 BRL | +2.01% | −41.15% | −52.14% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | 200.50 EUR | −20.91% | −41.22% | −11.75% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | 61.14 BRL | −11.65% | −45.14% | −49.89% |
| ZOE.DE | Zoetis Inc. | 65.68 EUR | −4.92% | −38.06% | −50.09% |
| FRE.DE | Fresenius SE & Co. KGaA | 46.04 EUR | +3.93% | −0.86% | +1.55% |
| 22UA.DE | BioNTech SE | 96.05 EUR | +19.17% | +16.49% | +8.53% |
| B1NT34.SA | BioNTech SE | 36.76 BRL | +25.42% | +11.90% | +3.26% |
| BNTX | BioNTech SE | $114.05 | +25.21% | +17.95% | +8.55% |
| MTD | Mettler-Toledo International Inc. | $1,402.25 | +4.94% | −0.65% | +8.72% |
| MTO.DE | Mettler-Toledo International Inc. | 1,222.00 EUR | +4.27% | +2.22% | +13.15% |
| 4503.T | Astellas Pharma Inc. | 2,430.50 JPY | +8.82% | +15.84% | +56.44% |
| LH | Labcorp Holdings Inc. | $337.68 | +12.12% | +34.52% | +23.25% |
| R1MD34.SA | ResMed Inc. | 243.85 BRL | 0.00% | −26.80% | −38.24% |
| INSM | Insmed Incorporated | $123.89 | +18.29% | −30.05% | −3.45% |
| DGX | Quest Diagnostics Incorporated | $244.51 | +5.46% | +41.95% | +38.70% |
| PHG | Koninklijke Philips N.V. | $27.52 | +9.99% | +5.62% | +3.60% |
| PHI1.DE | Koninklijke Philips N.V. | 23.61 EUR | +6.59% | +6.08% | +2.84% |
| INCY | Incyte Corporation | $129.72 | +9.13% | +27.90% | +53.04% |
| ROIV | Roivant Sciences Ltd. | $36.47 | +5.04% | +66.30% | +213.32% |
| I1NC34.SA | Incyte Corporation | 328.02 BRL | +11.19% | +18.38% | +41.91% |
| WST | West Pharmaceutical Services, Inc. | $348.48 | +5.27% | +26.29% | +41.31% |
| 4543.T | Terumo Corporation | 2,610.00 JPY | +14.02% | +16.18% | −1.19% |
| SIG.AX | Sigma Healthcare Limited | 2.85 AUD | −1.90% | −2.52% | −5.33% |
| STE | STERIS plc | $236.44 | +8.26% | −5.20% | −4.35% |
| DIM.PA | Sartorius Stedim Biotech S.A. | 191.20 EUR | +12.47% | −7.79% | +10.02% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | 192.70 EUR | +18.51% | −7.80% | +10.46% |
| GH | Guardant Health, Inc. | $164.92 | +13.37% | +62.10% | +166.52% |
| THC | Tenet Healthcare Corporation | $278.59 | +14.48% | +39.68% | +54.57% |
| GMAB | Genmab A/S | $34.36 | +19.31% | +7.98% | +41.34% |
| GE9.DE | GENMAB AS N | 283.30 EUR | +10.97% | +5.71% | −14.41% |
| GMAB.CO | Genmab A/S | 2,112.00 DKK | +10.69% | +5.23% | +33.08% |
| SRT3.DE | Sartorius Aktiengesellschaft | 243.10 EUR | +9.31% | −1.56% | +26.10% |
| S1TE34.SA | STERIS plc | 52.14 BRL | 0.00% | −19.10% | −18.78% |
| VTRS | Viatris Inc. | $16.72 | −5.22% | +36.33% | +62.88% |
| VIA.DE | Viatris Inc. | 14.01 EUR | −10.10% | +35.52% | +62.09% |
| ZBH | Zimmer Biomet Holdings, Inc. | $100.24 | +8.87% | +11.66% | −5.86% |
| QS51.DE | Straumann Holding AG | 99.50 EUR | −4.33% | −1.65% | +0.41% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | 121.92 BRL | +6.75% | +6.21% | −5.04% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 452.00 SEK | −3.17% | +36.80% | +54.48% |
| MEDP | Medpace Holdings, Inc. | $614.06 | +4.19% | +7.54% | +31.55% |
| JAZZ | Jazz Pharmaceuticals plc | $260.23 | +1.88% | +50.29% | +108.87% |
| ASND | Ascendis Pharma A/S | $252.99 | −0.17% | +18.61% | +32.89% |
| COLO-B.CO | Coloplast A/S | 462.50 DKK | +6.20% | −12.68% | −20.81% |
| CBHD.DE | Coloplast A/S | 61.54 EUR | +6.10% | −5.48% | +7.28% |
| IPN.PA | Ipsen S.A. | 162.60 EUR | +1.37% | +40.05% | +39.21% |
| BBIO | BridgeBio Pharma, Inc. | $80.40 | −4.42% | +2.77% | +70.01% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | 37.54 AUD | +11.83% | +15.97% | +13.60% |
| SRT.DE | Sartorius Aktiengesellschaft | 193.00 EUR | +9.53% | −0.29% | +22.06% |
| N1BI34.SA | Neurocrine Biosciences, Inc. | 39.72 BRL | −10.70% | −1.49% | +7.58% |
| 4507.T | Shionogi & Co., Ltd. | 2,942.00 JPY | +1.36% | +3.81% | +17.95% |
| SOLV | Solventum Corporation | $91.61 | +13.84% | +15.93% | +25.92% |
| NBIX | Neurocrine Biosciences, Inc. | $153.37 | −13.06% | +9.08% | +14.46% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | 36.07 BRL | +7.35% | −10.50% | +5.51% |
| C1OO34.SA | The Cooper Companies, Inc. | 39.92 BRL | +6.97% | −13.31% | −0.30% |
| ERF.PA | Eurofins Scientific SE | 73.26 EUR | +6.92% | +19.56% | +13.76% |
| ESF0.DE | Eurofins Scientific SE | 72.70 EUR | +6.29% | +17.51% | +11.02% |
| 7733.T | Olympus Corporation | 2,164.00 JPY | +20.09% | +8.49% | +26.42% |
| COO | The Cooper Companies, Inc. | $73.04 | +3.91% | −9.95% | −0.60% |
| CRL | Charles River Laboratories International, Inc. | $297.64 | +32.70% | +47.04% | +81.37% |
| PME.AX | Pro Medicus Limited | 188.01 AUD | +15.24% | −15.32% | −38.33% |
| EXEL | Exelixis, Inc. | $56.72 | +1.63% | +30.15% | +49.66% |
| RVTY | Revvity, Inc. | $124.84 | +15.52% | +27.37% | +35.78% |
| B1AX34.SA | Baxter International Inc. | 67.70 BRL | +23.99% | +27.70% | +2.30% |
| BAX | Baxter International Inc. | $26.29 | +12.64% | +34.89% | +7.91% |
| ICLR | ICON Public Limited Company | $168.91 | +0.08% | −10.47% | −1.65% |
| CORT | Corcept Therapeutics Incorporated | $123.57 | +35.61% | +223.48% | +79.56% |
| ORNBV.HE | Orion Oyj | 79.10 EUR | −2.04% | +26.66% | +16.59% |
| ORNAV.HE | Orion Oyj | 79.00 EUR | −1.86% | +27.30% | +17.12% |
| S1NN34.SA | Smith & Nephew plc | 31.62 BRL | 0.00% | −9.99% | −20.44% |
| BMRN | BioMarin Pharmaceutical Inc. | $66.12 | +9.71% | +11.22% | +13.03% |
| PEN | Penumbra, Inc. | $324.37 | +1.53% | +4.83% | +22.79% |
| FME.DE | Fresenius Medical Care AG | 40.14 EUR | −7.23% | +3.92% | −3.50% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | 52.70 EUR | +2.73% | +10.68% | +2.09% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | 166.77 BRL | +12.08% | −0.14% | +6.36% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $88.88 | +3.92% | +31.11% | +329.16% |
| FMS | Fresenius Medical Care AG | $23.51 | −5.47% | +4.03% | −3.29% |
| R1VT34.SA | Revvity, Inc. | 20.60 BRL | +3.00% | +10.27% | +22.81% |
| HALO | Halozyme Therapeutics, Inc. | $109.32 | +34.17% | +55.48% | +51.39% |
| TEM | Tempus AI, Inc. | $68.73 | +60.17% | +10.21% | −9.45% |
| SNN | Smith & Nephew plc | $29.22 | −6.11% | −9.78% | −19.49% |
| ELAN | Elanco Animal Health Incorporated | $25.09 | −1.26% | +11.41% | +41.03% |
| SN.L | Smith & Nephew plc | 1,082.00 GBP | −9.83% | −11.12% | −21.69% |
| EHC | Encompass Health Corporation | $120.14 | +5.50% | +13.17% | −1.16% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $512.16 | −7.09% | −13.76% | +24.24% |
| A1LG34.SA | Align Technology, Inc. | 208.52 BRL | −8.16% | −2.37% | +7.83% |
| DVA | DaVita Inc. | $177.80 | −24.76% | +55.27% | +29.47% |
| ALGN | Align Technology, Inc. | $159.61 | −5.02% | +2.29% | +10.11% |
| BTSG | BrightSpring Health Services, Inc. | $57.23 | −20.49% | +49.04% | +137.67% |
| AFW.DE | Align Technology, Inc. | 143.00 EUR | −6.14% | +7.68% | −54.37% |
| TECH | Bio-Techne Corporation | $72.33 | +0.99% | +21.65% | +28.12% |
| T1CH34.SA | Bio-Techne Corporation | 12.60 BRL | +4.13% | +17.24% | +23.42% |
| GMED | Globus Medical, Inc. | $82.96 | +6.02% | −4.97% | +35.16% |
| DVAI34.SA | DaVita Inc. | 913.56 BRL | −24.60% | +40.43% | +15.68% |
| I1QV34.SA | IQVIA Holdings Inc. | 84.64 BRL | −67.80% | −72.39% | −67.19% |
| CYTK | Cytokinetics, Incorporated | $77.46 | −3.92% | +25.48% | +109.29% |
| AXSM | Axsome Therapeutics, Inc. | $205.48 | −13.80% | +14.99% | +76.67% |
| GKOS | Glaukos Corporation | $181.39 | +19.41% | +63.83% | +98.13% |
| SMMT | Summit Therapeutics Inc. | $13.36 | +1.95% | −23.74% | −49.14% |
| IONS | Ionis Pharmaceuticals, Inc. | $63.57 | +13.60% | −20.21% | +52.01% |
| KRYS | Krystal Biotech, Inc. | $356.19 | +1.24% | +44.26% | +142.69% |
| KYMR | Kymera Therapeutics, Inc. | $126.64 | +15.07% | +74.05% | +202.82% |
| BIO | Bio-Rad Laboratories, Inc. | $390.34 | +23.37% | +27.87% | +31.26% |
| ENSG | The Ensign Group, Inc. | $179.02 | +0.53% | +2.97% | +5.44% |
| ABVX.PA | ABIVAX Société Anonyme | 98.10 EUR | −9.83% | −14.70% | +42.59% |
| MOH | Molina Healthcare, Inc. | $199.63 | +0.08% | +11.86% | +13.96% |
| BIM.PA | bioMérieux S.A. | 74.35 EUR | −0.80% | −32.10% | −37.52% |
| UHS | Universal Health Services, Inc. | $175.76 | +10.33% | −19.99% | −4.14% |
| ABVX | ABIVAX Société Anonyme | $117.93 | −7.87% | −11.84% | +52.25% |
| RDY | Dr. Reddy's Laboratories Limited | $12.34 | +4.84% | −10.97% | −14.66% |
| PRAX | Praxis Precision Medicines, Inc. | $368.02 | +16.54% | +28.50% | +684.02% |
| RGEN | Repligen Corporation | $181.69 | +38.63% | +10.55% | +49.84% |
| HSIC | Henry Schein, Inc. | $89.65 | +5.96% | +16.70% | +30.93% |
| U1HS34.SA | Universal Health Services, Inc. | 222.89 BRL | +8.20% | −29.31% | −10.02% |
| APGE | Apogee Therapeutics, Inc. | $134.85 | +0.42% | +77.95% | +265.05% |
| RHCPA.AX | Ramsay Health Care Limited | 107.57 AUD | −0.40% | +0.44% | +0.44% |
| PTGX | Protagonist Therapeutics, Inc. | $150.59 | +11.09% | +72.73% | +164.75% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.